Breaking News Instant updates and real-time market news.

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

, BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

05:20
09/22/17
09/22
05:20
09/22/17
05:20

Becton Dickinson initiated with an Outperform at Wells Fargo

Wells Fargo analyst Larry Biegelsen started Becton Dickinson (BDX) with an Outperform rating and $225 price target. The analyst sees potential upside to C.R. Bard (BCR) acquisition accretion and believes any potential impact from the hurricanes in Q4 will be short-term.

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

BDX Becton Dickinson
$191.56

-2.44 (-1.26%)

05/23/17
MSCO
05/23/17
NO CHANGE
MSCO
Medtech Technology sector upgraded to Attractive from In-Line at Morgan Stanley
Morgan Stanley upgraded the Medtech Technology sector to Attractive saying structural fundamentals have improved and recent acceleration will likely continue, driving further multiple expansion.
06/30/17
RAJA
06/30/17
UPGRADE
Target $226
RAJA
Strong Buy
Becton Dickinson upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Lawrence Keusch upgraded Becton Dickinson to Strong Buy from Outperform and increased its price target to $226 from $210 and believes it should be a core holding based an an above average outlook for 5-6% organic growth and mid-teens earnings increases with further potential upside. The analyst views the C.R. Bard acquisition as a sold strategic fit with an accelerating growth profile given its deep R&D pipeline and sizeable addressable market opportunities. Post close, he sees strong free cash flow generation of $10B from 2018-2020, allowing the company to rapidly deleverage to 3x in 2020 from 4.7x.
06/30/17
06/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying Cabot 's gross Marcellus takeaway capacity will increase to 3.7 bcf/d from 2bcf/d by end of 2018 and positioned to increase free cash flow to $2B from $872M per year for 25 years. 2. Becton Dickinson (BDX) upgraded to Strong Buy from Outperform at Raymond James with analyst Lawrence Keusch saying he believes it should be a core holding based an an above average outlook for 5%-6% organic growth and mid-teens earnings increases with further potential upside. 3. Walgreens Boots Alliance (WBA) upgraded to Buy from Hold at Needham. 4. ManTech (MANT) upgraded to Buy from Hold at Loop Capital with analyst Joseph Vafi saying he sees "company-specific and secular catalysts" driving improving fundamentals and upward revisions to consensus estimates. 5. D.R. Horton (DHI) upgraded to Outperform from Market Perform at Raymond James with the firm saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
COWN
09/12/17
NO CHANGE
COWN
Cowen says cervical cancer recommendations a risk for Hologic, Becton Dickinson
Cowen analyst Doug Schenkel noted that the US Preventive Services Task Force recently released a draft recommendation on cervical cancer screening, which no longer recommends cotesting with both an HPV assay and cytology, which would be a negative for Hologic (HOLX) and Becton Dickinson (BDX) if the draft is implemented. If the draft is implemented, it is likely a positive for Roche (RHHBY), the only vendor with a primary screening HPV assay that is FDA approved, added Schenkel. However, the final recommendation statement can be materially different from the draft, he said.
BCR C.R. Bard
$317.37

-1.19 (-0.37%)

04/24/17
MSCO
04/24/17
DOWNGRADE
MSCO
Equal Weight
C.R. Bard downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lewis downgraded C.R. Baird (BCR) to Equal Weight following the acquisition announcement by Becton Dickinson (BDX) saying a higher bid is unlikely.
04/25/17
BMOC
04/25/17
DOWNGRADE
BMOC
Market Perform
C.R. Bard downgraded to Market Perform from Outperform at BMO Capital
C.R. Bard (BCR) is being acquired by Beckton Dickinson for (BDX) for $317 per share.
04/25/17
RAJA
04/25/17
DOWNGRADE
RAJA
Market Perform
C.R. Bard downgraded to Market Perform from Strong Buy at Raymond James
C.R. Bard (BCR) is being acquired by Beckton Dickinson for (BDX) for $317 per share.
04/25/17
LEER
04/25/17
NO CHANGE
Target $317
LEER
Market Perform
C.R. Bard price target raised to $317 from $246 at Leerink
Leerink analyst Richard Newitter raised his price target for C.R. Bard (BCR) to $317 from $246 following the announced acquisition price from Becton Dickinson (BDX). The analyst reiterates a Market Perform rating as he believes the deal price fully values C.R. Bard and sees limited risk of a competitive bid or barriers from the FTC.

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Hot Stocks
UnitedHealth sees FY18 adj. EPS in-line with consensus »

Consensus $10.85. Expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SRAX

Social Reality

$2.87

-0.19 (-6.21%)

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Conference/Events
Social Reality to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

HOG

Harley-Davidson

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Hot Stocks
Breaking Hot Stocks news story on Harley-Davidson »

Harley-Davidson says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

09:10
10/17/17
10/17
09:10
10/17/17
09:10
General news
FX Action: The dollar »

FX Action: The dollar…

TDC

Teradata

$32.97

-0.24 (-0.72%)

, GE

General Electric

$23.36

0.38 (1.65%)

09:09
10/17/17
10/17
09:09
10/17/17
09:09
Hot Stocks
GE Aviation and Teradata partner for airline analytics solutions »

GE (GE) Aviation and…

TDC

Teradata

$32.97

-0.24 (-0.72%)

GE

General Electric

$23.36

0.38 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 02

    Nov

V

Visa

$108.30

-0.36 (-0.33%)

09:08
10/17/17
10/17
09:08
10/17/17
09:08
Hot Stocks
Visa and Billtrust partner for B2B virtual card acceptance »

Visa and Billtrust today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 29

    Nov

DGX

Quest Diagnostics

$91.53

0.47 (0.52%)

09:07
10/17/17
10/17
09:07
10/17/17
09:07
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

HOG

Harley-Davidson

09:07
10/17/17
10/17
09:07
10/17/17
09:07
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson Q3 beat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HOG

Harley-Davidson

$46.57

-0.05 (-0.11%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
Harley-Davidson says Q3 international performance down »

Sees tremendous interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AMDA

Amedica

$0.29

-0.01049 (-3.46%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
Amedica receives positive Nasdaq listing decision »

Amedica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$13.51

0.31 (2.35%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
MiMedx warns of fake emails »

MiMedx Group warned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

BUD

AB InBev

$125.72

0.36 (0.29%)

09:05
10/17/17
10/17
09:05
10/17/17
09:05
Hot Stocks
Anheuser-Busch, Convoy sign multiyear partnership to advance shipping operations »

Anheuser-Busch and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

09:05
10/17/17
10/17
09:05
10/17/17
09:05
General news
U.S. equities are trading sideways »

U.S. equities are trading…

BKI

Black Knight

$46.85

0.05 (0.11%)

09:04
10/17/17
10/17
09:04
10/17/17
09:04
Hot Stocks
Black Knight, Homebot announce strategic alliance »

Black Knight announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MS

Morgan Stanley

$48.94

0.64 (1.33%)

09:03
10/17/17
10/17
09:03
10/17/17
09:03
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

CELG

Celgene

$136.71

0.25 (0.18%)

09:03
10/17/17
10/17
09:03
10/17/17
09:03
Initiation
Celgene initiated  »

Celgene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Roku expands further into Latin America, to launch two players in region »

Roku, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$0.52

-0.0206 (-3.81%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Neothetics, Evofem Biosciences announce all-stock merger »

Neothetics (NEOT) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Hot Stocks
Roku launches Roku Express in Canada »

Roku, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Syndicate
Abeona Therapeutics 5M share Spot Secondary priced at $16.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 17

    Oct

NFLX

Netflix

09:00
10/17/17
10/17
09:00
10/17/17
09:00
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Fed funds futures are modestly lower, having unwound early gains »

Fed funds futures are…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production to be reported at 09:15 »

September Industrial…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

September Industrial…

ACN

Accenture

$139.09

-0.11 (-0.08%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Hot Stocks
Accenture enters into exclusive negotiations to acquire Altima »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.